In vivo genome-wide CRISPR screens identify SOCS1 as a major intrinsic checkpoint of CD4 <sup>+</sup> Th1 cell response

Aurélien Sutra Del Galy(Assistance Publique – Hôpitaux de Paris), Laurie Menger(Inserm)
bioRxiv (Cold Spring Harbor Laboratory)
April 12, 2021
10.1101/2021.04.12.439455
Cited by 5

Related Papers

Table S3 from Gut Microbiota Modulation through &lt;i&gt;Akkermansia&lt;/i&gt; spp&lt;i&gt;.&lt;/i&gt; Supplementation Increases CAR T-cell Potency
|Unknown|2025|0
Table S5 from Gut Microbiota Modulation through &lt;i&gt;Akkermansia&lt;/i&gt; spp&lt;i&gt;.&lt;/i&gt; Supplementation Increases CAR T-cell Potency
|Unknown|2025|0
Table S2 from Gut Microbiota Modulation through &lt;i&gt;Akkermansia&lt;/i&gt; spp&lt;i&gt;.&lt;/i&gt; Supplementation Increases CAR T-cell Potency
|Unknown|2025|0
Supplementary Figures S1 to S9 from Gut Microbiota Modulation through &lt;i&gt;Akkermansia&lt;/i&gt; spp&lt;i&gt;.&lt;/i&gt; Supplementation Increases CAR T-cell Potency
|Unknown|2025|0
Table S1 from Gut Microbiota Modulation through &lt;i&gt;Akkermansia&lt;/i&gt; spp&lt;i&gt;.&lt;/i&gt; Supplementation Increases CAR T-cell Potency
|Unknown|2025|0